Superworth

Celularity market cap CELU

Share price times shares outstanding: what the whole company sells for, since 2019.

Today, Nov 2, 2026
$26M
Highest close in our data
$1.7B
May 2022

Celularity is worth $26M at the close on Nov 2, 2026, at $0.80 a share.

That is down 45% over the last year and down 97% over five years.

Its highest close in our data was $1.7B in May 2022.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$26M$17.9M$51.9M−31%
2025$38M$26.1M$94.4M−25%
2024$50.4M$31.7M$119.8M+7%
2023$47.2M$34.4M$153.7M−75%
2022$187.1M$166.8M$1.7B−70%
2021$632.1M$233.6M$1.1B+60%
2020$395.3M$338.9M$429.1M+11%
2019$357.6M$280.9M$357.6Mn/a

Against its peers

Companies in Drug Manufacturers - General nearest Celularity's size, closest first, today.

CompanyMarket cap
CELUCelularity$26M
ATNMActinium Pharmaceuticals$45M
SPROSpero Therapeutics$60.6M
LFVNLifevantage$73.5M
NATRNatures Sunshine Products$211.5M
Peer median$67M

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Celularity

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.